JP2022506841A5 - - Google Patents

Info

Publication number
JP2022506841A5
JP2022506841A5 JP2021524452A JP2021524452A JP2022506841A5 JP 2022506841 A5 JP2022506841 A5 JP 2022506841A5 JP 2021524452 A JP2021524452 A JP 2021524452A JP 2021524452 A JP2021524452 A JP 2021524452A JP 2022506841 A5 JP2022506841 A5 JP 2022506841A5
Authority
JP
Japan
Prior art keywords
population
hematopoietic tissue
cells
tissue sample
lymphocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021524452A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022506841A (ja
JP7665513B2 (ja
Filing date
Publication date
Priority claimed from GBGB1818243.6A external-priority patent/GB201818243D0/en
Application filed filed Critical
Publication of JP2022506841A publication Critical patent/JP2022506841A/ja
Publication of JP2022506841A5 publication Critical patent/JP2022506841A5/ja
Priority to JP2025064036A priority Critical patent/JP2025106453A/ja
Application granted granted Critical
Publication of JP7665513B2 publication Critical patent/JP7665513B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021524452A 2018-11-08 2019-11-08 細胞を単離及び拡大する方法 Active JP7665513B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025064036A JP2025106453A (ja) 2018-11-08 2025-04-09 細胞を単離及び拡大する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1818243.6 2018-11-08
GBGB1818243.6A GB201818243D0 (en) 2018-11-08 2018-11-08 Methods for isolating and expanding cells
PCT/GB2019/053166 WO2020095059A1 (en) 2018-11-08 2019-11-08 Methods for isolating and expanding cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025064036A Division JP2025106453A (ja) 2018-11-08 2025-04-09 細胞を単離及び拡大する方法

Publications (3)

Publication Number Publication Date
JP2022506841A JP2022506841A (ja) 2022-01-17
JP2022506841A5 true JP2022506841A5 (cg-RX-API-DMAC7.html) 2022-11-25
JP7665513B2 JP7665513B2 (ja) 2025-04-21

Family

ID=64739360

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021524452A Active JP7665513B2 (ja) 2018-11-08 2019-11-08 細胞を単離及び拡大する方法
JP2025064036A Pending JP2025106453A (ja) 2018-11-08 2025-04-09 細胞を単離及び拡大する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025064036A Pending JP2025106453A (ja) 2018-11-08 2025-04-09 細胞を単離及び拡大する方法

Country Status (14)

Country Link
US (2) US12460180B2 (cg-RX-API-DMAC7.html)
EP (1) EP3877510A1 (cg-RX-API-DMAC7.html)
JP (2) JP7665513B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210111747A (cg-RX-API-DMAC7.html)
CN (1) CN113423821A (cg-RX-API-DMAC7.html)
AU (2) AU2019374489B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021008166A2 (cg-RX-API-DMAC7.html)
CA (1) CA3117913A1 (cg-RX-API-DMAC7.html)
EA (1) EA202190864A1 (cg-RX-API-DMAC7.html)
GB (1) GB201818243D0 (cg-RX-API-DMAC7.html)
IL (1) IL282901A (cg-RX-API-DMAC7.html)
MX (1) MX2021005480A (cg-RX-API-DMAC7.html)
PH (1) PH12021551038A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020095059A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201818243D0 (en) 2018-11-08 2018-12-26 Gammadelta Therapeutics Ltd Methods for isolating and expanding cells
JP2022545196A (ja) 2019-08-16 2022-10-26 ガンマデルタ セラピューティクス リミテッド 抗tcrデルタ可変1抗体の治療的使用
CA3148588A1 (en) 2019-08-16 2021-02-25 GammaDelta Therapeutics Limited Ex vivo gamma delta t cell populations
GB202002581D0 (en) 2020-02-24 2020-04-08 Gammadelta Therapeutics Ltd Novel antibodies
ES2943063T5 (en) 2020-08-14 2026-05-05 Gammadelta Therapeutics Ltd Multispecific anti-tcr delta variable 1 antibodies
KR20230160253A (ko) 2021-02-17 2023-11-23 감마델타 테라퓨틱스 엘티디 항-tcr 델타 가변 1 항체
GB202105113D0 (en) 2021-04-09 2021-05-26 Gammadelta Therapeutics Ltd Novel method
CA3228168A1 (en) 2021-08-03 2023-02-09 Gammadelta Therapeutics Ltd Engineering of gamma delta t cells and compositions thereof
GB202204926D0 (en) * 2022-04-04 2022-05-18 Gammadelta Therapeutics Ltd Method for expanding gammadelta T cells
PE20242341A1 (es) 2022-04-04 2024-12-12 Gammadelta Therapeutics Ltd Blindaje genetico novedoso
WO2025017531A1 (en) * 2023-07-20 2025-01-23 Takeda Pharmaceutical Company Limited Grid-free methods for making gamma delta t cells

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028176A (en) 1996-07-19 2000-02-22 Bayer Corporation High-affinity interleukin-4 muteins
US7078034B2 (en) 1999-01-28 2006-07-18 Palmetto Health Alliance In vitro activated γ δ lymphocytes
CN101120083B (zh) 2003-10-08 2013-03-27 威尔森沃尔夫制造公司 利用透气性材料进行细胞培养的方法及装置
EP1777294A1 (en) 2005-10-20 2007-04-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
US20070122413A1 (en) 2005-11-28 2007-05-31 Sivakumar Pallavur V Il-21 antagonists
JP4659785B2 (ja) * 2007-06-15 2011-03-30 トヨタ自動車株式会社 内燃機関の燃料噴射制御装置
US8529883B2 (en) * 2010-05-07 2013-09-10 Fibrocell Technologies, Inc. Dosage unit formulations of autologous dermal fibroblasts
WO2012088446A1 (en) 2010-12-22 2012-06-28 Board Of Trustees Of The Leland Stanford Junior University Superagonists and antagonists of interleukin-2
EP2710123B1 (en) 2011-05-19 2017-07-12 Instituto de Medicina Molecular Cell line of lymphocytes comprising gamma-delta t cells, composition and production method thereof
US9907820B2 (en) 2013-10-25 2018-03-06 Board Of Regents, The University Of Texas System Polyclonal gamma delta T cells for immunotherapy
UA123821C2 (uk) 2014-06-11 2021-06-09 Полібіосепт Гмбх Композиція для експансії лімфоцитів in vitro
RU2756247C2 (ru) 2014-11-17 2021-09-28 Эдисет Био, Инк. Генетически модифицированные гамма дельта т-клетки
JP6799895B2 (ja) 2015-06-09 2020-12-16 リンファクト−リンフォサイト アクティベイション テクノロジーズ エス.エー. TCRγδ+T細胞の生産方法
CN108473958A (zh) * 2015-10-30 2018-08-31 癌症研究技术有限公司 非造血组织驻留γδT细胞的扩增及这些细胞的用途
TWI826360B (zh) 2016-11-17 2023-12-21 美商艾歐凡斯生物治療公司 殘餘腫瘤浸潤性淋巴細胞及製備和使用彼之方法
AU2018205234B2 (en) 2017-01-06 2024-09-19 Iovance Biotherapeutics, Inc. Expansion of tumor infiltrating lymphocytes (TILs) with tumor necrosis factor receptor superfamily (TNFRSF) agonists and therapeutic combinations of TILs and TNFRSF agonists
GB201707048D0 (en) * 2017-05-03 2017-06-14 King S College London Expansion of gamma delta cells, compositions, and methods of use thereof
WO2018229163A1 (en) 2017-06-14 2018-12-20 King's College London Methods of activating v delta 2 negative gamma delta t cells
GB201818243D0 (en) 2018-11-08 2018-12-26 Gammadelta Therapeutics Ltd Methods for isolating and expanding cells
KR20210111746A (ko) 2018-11-08 2021-09-13 감마델타 테라퓨틱스 리미티드 세포를 단리 및 증식하는 방법

Similar Documents

Publication Publication Date Title
JP2022506836A5 (cg-RX-API-DMAC7.html)
PH12021551038A1 (en) Methods for isolating and expanding cells
EP3649961B1 (en) Apparatuses for amniotic fluid collection
CN105765060B (zh) 羊膜间充质系细胞组合物的制造方法和冷冻保存方法、以及治疗剂
Najar et al. Bone marrow mesenchymal stromal cells induce proliferative, cytokinic and molecular changes during the T cell response: the importance of the IL-10/CD210 axis
MX2016016251A (es) Expansion de linfocitos con composicion de citocinas para inmunoterapia celular activa.
JP2020018315A5 (cg-RX-API-DMAC7.html)
PH12021551037A1 (en) Methods for isolating and expanding cells
JP2020518289A5 (cg-RX-API-DMAC7.html)
JP2016506968A5 (cg-RX-API-DMAC7.html)
Martrus et al. Proliferative capacity exhibited by human liver-resident CD49a+ CD25+ NK cells
EP4234019A3 (en) Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof
JP2014508527A5 (cg-RX-API-DMAC7.html)
ATE479743T1 (de) Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays
WO2017213469A3 (ko) 남조류 스피룰리나 추출물을 함유하는 세포 배양액, 이의 제조방법, 및 이를 이용한 세포의 배양방법
JP2007089442A (ja) 骨格筋芽細胞の分離方法
CN105176822A (zh) 一种人类肠道益生菌的优化分离方法
Sung et al. Enrichment of cancer-initiating cells from colon cancer cells through porous polymeric membranes by a membrane filtration method
CN111603482A (zh) 一种用于免疫功能调节的间充质干细胞药物及制备方法
EP4494668A3 (en) Convertible fluid processing assemblies
Ducret et al. A standardized procedure to obtain mesenchymal stem/stromal cells from minimally manipulated dental pulp and Wharton’s jelly samples
JP6774420B2 (ja) 培養容器の表示用シール
JP2023525345A5 (cg-RX-API-DMAC7.html)
Bhatia A simple method for isolation of rest of trypsinized stem cells with magnetic beads
EP4130710A3 (en) Label free cell sorting